Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Human loss-of-function variants suggest that partial LRRK... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinsons disease
0
Authors
Nicola Whiffin
39 more
Nicola Whiffin
•
Irina Armean
37 more
•
Daniel MacArthur
Published
September 18, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Medicine
Internal Medicine
Genomics
Show all topics
DOI
10.1101/561472
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Bioinformatics
Medicine
Internal Medicine
Genomics
Show all topics
DOI
10.1101/561472
License
CC-BY
Other Formats
PDF
